It is important to note that when expressed in cancer, IGF-II is secreted as partially-processed forms generated by retention of the E domain, which bears O-glycosylation sites, allowing enzymatic attachment of glycosyl groups, conferring in this way its characteristic high molecular weight and the name of “big-IGF-II” [31,32]. This evidence concerns the gene IGF2 and cancer.